Skip to main content
OpenTrials

Clinical trial condition

Neuroendocrine Carcinoma

Explore clinical trials studying Neuroendocrine Carcinoma. Study availability and eligibility vary by location and protocol.

52 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Neuroendocrine Carcinoma trial results

Completed

Safety and Efficacy of Atiprimod Treatment for Patients With Low to Intermediate Grade Neuroendocrine Carcinoma

NCT00388063

Conditions
Adenocarcinoma, Carcinoid Tumor, Carcinoma, +9 more
Locations
  • Hematology Oncology Services of Arkansas Little Rock, Arkansas, United States
  • Cedars Sinai Outpatient Cancer Center at the Samuel Oschin Comprehensive Cancer Institute Los Angeles, California, United States
  • H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
  • Robert H. Lurie Comprehensive Cancer Center of Northwestern Chicago, Illinois, United States
View Trial Details
Active, Not Recruiting

A Study in Participants With Advanced Cancers Associated With Expression of DLL3 (MK-6070-001/HPN328-4001)

NCT04471727

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +26 more
Locations
  • Cedar-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute Los Angeles, California, United States
  • University of California San Francisco San Francisco, California, United States
  • University of Colorado Aurora, Colorado, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

Study of CVM-1118 for Patients With Advanced Neuroendocrine Tumors

NCT03600233

Conditions
Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +21 more
Locations
  • Chang Gung Memorial Hospital, KaoHsiung Kaohsiung City, Taiwan
  • Kaohsiung Medical University Hospital Kaohsiung City, Taiwan
  • New Taipei Municipal TuCheng Hospital New Taipei City, Taiwan
  • China Medical University Hospital Taichung, Taiwan
View Trial Details
Active, Not Recruiting

Neuroendocrine Tumors - Patient Reported Outcomes

NCT05064150

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +11 more
Locations
  • University of Florida Gainesville, Florida, United States
  • University of Iowa Iowa City, Iowa, United States
  • University of Kansas Medical Center Research Institute, Inc Kansas City, Kansas, United States
  • Regents of the University of Michigan Ann Arbor, Michigan, United States
View all 14 locations
View Trial Details

Related conditions